Calcipotriene recalls

The FDA has published 4 recalls involving Calcipotriene since 2017. The latest was reported on 7 Jun 2023. Most were for packaging defects. Akorn has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls4since 2017

Last 12 months0reported

Class I00% of total

Ongoing1latest 7 Jun 2023

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 0Jan '25 0 0 0Apr 0 0 0Jul 0 0 0Oct 0 0 0Jan '26 0 0 0Apr 0 0 0Jul 0 0

Severity split

Class I 0 0%Class II 3 75%Class III 1 25%

Why calcipotriene is recalled

Companies

Akorn250%
LEO Pharma250%

Brands

Calcipotriene125%
Taclonex125%

By year

2023125%
2022125%
2017250%

Ongoing calcipotriene recalls

1 active

Reported	Class	Recall	Company	Reason	Where
7 Jun 2023Drug	CLASS II	Calcipotriene Topical Solution, 0.005% (Scalp Solution) recalled	Akorn	Potency & Assay	Nationwide

All calcipotriene recalls, newest first

4 total

Reported	Class	Recall	Company	Reason	Where
7 Jun 2023Drug	CLASS II	Calcipotriene Topical Solution, 0.005% (Scalp Solution) recalled	Akorn	Potency & Assay	Nationwide
6 Jul 2022Drug	CLASS II	Calcipotriene Topical Solution, 0.005% (Scalp Solution) recalled	Akorn	Other	Nationwide
15 Mar 2017Drug	CLASS II	Calcipotriene Cream recalled by Leo PharmaCalcipotriene	LEO Pharma	Labeling Errors	Nationwide
22 Feb 2017Drug	CLASS III	Taclonex (calcipotriene and betamethasone dipropionate) recalledTaclonex	LEO Pharma	Packaging Defects	Nationwide

Should you stop taking Calcipotriene?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.